Sara Zaknoen - May 21, 2021 Form 4 Insider Report for aTYR PHARMA INC (LIFE)

Role
Director
Signature
Nancy Denyes, Attorney-In-Fact
Stock symbol
LIFE
Transactions as of
May 21, 2021
Transactions value $
$0
Form type
4
Date filed
5/25/2021, 09:02 PM
Next filing
Apr 28, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LIFE Stock Option (right to buy) Award $0 +2.29K $0.00 2.29K May 21, 2021 Common Stock 2.29K $4.45 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option shall vest and become exercisable in 36 equal monthly installments beginning June 21, 2021, such that this option will be fully exercisable on May 21, 2024, subject to the recipient's continued service on the Issuer's Board of Directors.